Synthesis of a FTO Inhibitor with Anticonvulsant Activity-Reference-Cited by-同舟云学术

Synthesis of a FTO Inhibitor with Anticonvulsant Activity

Published:2014-06-05 Issue:8 Volume:5 Page:658-665
ISSN:1948-7193
Container-title:ACS Chemical Neuroscience
language:en
Short-container-title:ACS Chem. Neurosci.

Author:

Zheng Guanqun¹,Cox Thomas,Tribbey Leah,Wang Gloria Z.¹,Iacoban Paulina,Booher Matthew E.²,Gabriel Gregory J.²,Zhou Lu³,Bae Nancy,Rowles Joie,He Chuan¹,Olsen Mark J.

Affiliation:

1. Department of Chemistry, University of Chicago, 929 E. 57th St., Chicago, Illinois 60637, United States

2. Department of Chemistry and Biochemistry, Kennesaw State University, 1000 Chastain Rd., Box 1203, Kennesaw, Georgia 30144, United States

3. School of Pharmacy, Fudan University, 826 Zhangheng Rd., Shanghai 201203, P. R. China

Publisher

American Chemical Society (ACS)

Subject

Cell Biology,Cognitive Neuroscience,Physiology,Biochemistry,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/cn500042t

Reference45 articles.

1. Perspectives on the Development of Antioxidant Antiepileptogenic Agents

2. Therapeutic approaches to epileptogenesis-Hope on the horizon

3. The NIH/NINDS Anticonvulsant Screening Program (ASP): Recommendations from the working group’s 2012 review of the Program

4. Key factors in the discovery and development of new antiepileptic drugs

5. Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medicinal chemistry aspects of fat mass and obesity associated protein: structure, function and inhibitors;Future Medicinal Chemistry;2024-08-05

2. Small molecules that regulate the N6-methyladenosine RNA modification as potential anti-cancer agents;European Journal of Medicinal Chemistry;2024-08

3. Clinical Perspectives in Epitranscriptomics;Current Opinion in Genetics & Development;2024-08

4. Role of m6A modifications in immune evasion and immunotherapy;Medical Oncology;2024-05-18

5. Small molecule inhibitors targeting m6A regulators;Journal of Hematology & Oncology;2024-05-06